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Melanin-concentrating hormone receptor 1 (MCHR1) is a G-protein-coupled receptor
(GPCR) that plays an important role in feeding by coupling to Gαq- and Gαi-mediated
signal transduction pathways. To interrogate the molecular basis for MCHR1 activation,
we analyzed the effect of a series of site-directed mutations on rat MCHR1 function. In
the highly conserved NPxxY(x)5,6F domain of GPCRs, the phenylalanine residue is involved
in structural constraints; replacement with alanine generally leads to impaired/lost GPCR
function. However, Phe-to-Ala (F318A) mutation in MCHR1 had no significant effect on
the level of cell surface expression and receptor signaling. By analyzing a further series
of mutants, we found that Phe-to-Lys substitution (F318K) caused the most significant
reduction in the EC50 value of MCH for calcium mobilization without affecting receptor
expression at the cell surface. Interestingly, GTPγS-binding, which monitors Gαi activation,
was not modulated by F318K. Our results, combined with computer modeling, provide
new insight into the role of Phe in the NPxxY(x)5,6F motif as a structurally critical site for
receptor dynamics and a determinant of Gα protein interaction.
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INTRODUCTION
Mammalian melanin-concentrating hormone (MCH), a cyclic
nonadecapeptide produced predominantly by neurons of the lat-
eral hypothalamus, is involved in the regulation of food intake
behavior and energy expenditure (Bittencourt et al., 1992; Rossi
et al., 1997; Shimada et al., 1998). MCH acts via two G-protein-
coupled receptors (GPCRs), Melanin-concentrating hormone
receptor 1 (MCHR1), and MCHR2 (Chambers et al., 1999;
Saito et al., 1999; An et al., 2001), of which MCHR2 is not
functionally present in rodents (Tan et al., 2002). MCHR1 is
widely expressed at high levels in the brain (Saito et al., 2001).
Because mice lackingMCHR1 are lean, hyperactive, hyperphagic,
and hypermetabolic (Chen et al., 2002; Marsh et al., 2002),
MCHR1 is viewed as the physiologically relevant MCH receptor
in rodents. In support of this belief, selective MCHR1 antagonists
decrease food intake and body weight in both normal and diet-
induced obese rats (Takekawa et al., 2002; Shearman et al., 2003).
Moreover, some of these antagonists exhibit anti-depressant
and anxiolytic effects (Borowsky et al., 2002; Georgescu et al.,
2005). Therefore, the MCH-MCHR1 system could be an impor-
tant target for the treatment of obesity and certain mood
disorders.
Abbreviations: ECL, enhanced chemiluminescence; ER, endoplasmic reticulum;
ERK, extracellular signal-regulated kinase; FBS, fetal bovine serum; GPCR,
G-protein-coupled receptor; HEK293T, human embryonic kidney 293; helix 8,
eighth cytoplasmic helix; i1, intracellular loop 1; i2, intracellular loop 2; i3, intracel-
lular loop 3; MCH, melanin-concentrating hormone; MCHR1, MCHR1 receptor;
MCHR2, MCHR2 receptor; PTX, pertussis-toxin; TM, transmembrane.
In mammalian cells transfected with MCHR1, MCH is able
to activate multiple signaling pathways including calcium mobi-
lization, activation of extracellular signal-regulated kinase (ERK)
and inhibition of cyclic AMP generation through Gαi/o- and
Gαq-coupled pathways (Chambers et al., 1999; Saito et al., 1999;
Hawes et al., 2000). Several studies have reported structural deter-
minants of MCHR1 activation by MCH. Biochemical analysis
of MCHR1 using molecular modeling identified Asp123 in the
third transmembrane domain (TM3) as being crucial for ligand
binding (Macdonald et al., 2000). In addition, Thr255, which
is located at the junction of intracellular loop 3 (i3) and trans-
membrane domain 6 (TM6), is critically important for receptor
folding and correct trafficking to the cell surface (Fan et al.,
2005). We previously identified that Asn23 in the extracellu-
lar N-terminus contributed mainly to N-linked glycosylation of
MCHR1 and is necessary for MCHR1 cell surface expression,
ligand binding and signal transduction (Saito et al., 2003). We
also showed that Arg155 in intracellular loop 2 (i2) and a prox-
imal dibasic motif (Arg319/Lys320) in eighth cytoplasmic helix
(helix 8: a common short amphiphilic helical domain in the prox-
imal C-terminal tail) are important for signaling (Tetsuka et al.,
2004; Saito et al., 2005), whereas the distal part of the C-terminal
tail is necessary for receptor internalization (Saito et al., 2004).
However, despite numerous mutagenesis studies, the residues that
determine G protein selectivity (Gαq vs. Gαi) have yet to be
identified.
The NPxxY(x)5,6F sequence, located at the junction between
TM7 and the connecting cytosolic helix 8, is conserved in most
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rhodopsin family (class A) GPCRs, including the MCH receptor
(Gether, 2000; Huynh et al., 2009). The high degree of conser-
vation of this motif suggests that it must play very important
roles in rhodopsin family GPCR functionality. Mutations in the
NPxxY(x)5,6F motif are reported to affect ligand binding, G
protein coupling and receptor phosphorylation. In rhodopsin,
the prototypical GPCR, the Tyr and Phe residues within the
motif were both found to be critical for proper light-induced
conformational changes from the ground state (Acharya and
Karnik, 1996). Moreover, the Phe residue is reported to be
essential for export of the β1-adrenergic receptor (β1-AR), α2B-
adrenergic receptor (α2B-AR) and A1 adenosine receptor from
the endoplasmic reticulum (ER) (Delos Santos et al., 2006;
Duvernay et al., 2009; Málaga-Diéguez et al., 2010). Indeed,
Phe-to-Ala substitution in the α2B-AR dramatically reduced
cell-surface expression by 91% compared with their wild-type
variants (Duvernay et al., 2009). To determine the role of
the conserved Phe residue (F318) in the NPxxY(x)5,6F motif
present in the MCHR1, we examined the effect of site-directed
mutagenesis of this residue on receptor function, and noted
a most significant increase in calcium mobilization relative to
wild-type after substitution of F318 with a positively-charged
lysine residue. Our analyses show that Lys replacement muta-
tion (F318K) produces an efficient signaling property that selec-
tively increases Gαq-mediated pathway without changing cell
surface expression. We further discuss the significance of the posi-
tion of Phe318 using a homology docking model of MCHR1
with Gαq and Gαi proteins, respectively. To date, this is the
first study to provide meaningful insights into the relationship
between conformational changes in MCHR1 and G protein acti-
vation.
MATERIALS AND METHODS
cDNA CONSTRUCTS FOR MCHR1 ANDMUTANT RECEPTORS
The generation of a cDNA encoding a Flag epitope tag before the
first methionine in rat MCHR1 (NM_031758/GenBank/EMBL)
was described previously (Saito et al., 2003). Single-substitution
mutations of the NPxxY(x)5,6F domain were produced by
oligonucleotide-mediated site-directed mutagenesis using a
QuikChange site-directed mutagenesis kit (Stratagene, La Jolla,
CA, USA). All mutations in the MCHR1 cDNA sequence were
confirmed by sequencing analysis. Mutated MCHR1 cDNAs were
excised by digestion with EcoRI and XhoI and inserted into the
pcDNA3.1 expression vector.
CELL CULTURE AND TRANSIENT TRANSFECTION
HEK293T cells were cultured in DMEM containing 10%
fetal bovine serum. The plasmid DNA was mixed with
LipofectAMINE PLUS transfection reagent (Life Technologies
Corporation, Carlsbad, CA, USA) and the mixture was
diluted with OptiMEM and added to the cells (Saito et al.,
2003). For western blotting and GTPγS-binding assays,
the cells were re-seeded onto 6-well plates. Cells were re-
plated onto LAB-TEK 8-well plates (Nunc, Rochester, NY,
USA) for immunocytochemistry, and onto 24- and 96-well
plates (BIOCOAT, Becton Dickinson, Belford, MA, USA) for
FACScan flow cytometric analysis and the calcium influx assay,
respectively. The re-plated cells were cultured for a further
18–24 h.
WESTERN BLOTTING FOR MCHR1
To generate whole cell extracts, transiently-transfected HEK293T
cells were lysed with ice-cold sodium dodecyl sulfate sam-
ple buffer [50mM Tris-HCl (pH 6.8), 2% sodium dodecyl
sulfate, 50mM β-mercaptoethanol, and 10% glycerol], then
homogenized at 4◦C by sonication (SONICAOR Ultrasonic
processor W-225, Wakenyaku Ltd., Kyoto, Japan) using 5×30
s bursts at 20% power. Aliquots containing 15μg of total
protein were separated by SDS-PAGE and electro-transferred
to Hybond-P PVDF membranes (GE Healthcare UK Ltd.,
Little Chalfont, UK). After blocking with 5% skim milk,
membrane-expressed Flag-MCHR1 was detected using 0.5μg/ml
anti-Flag M2 antibody (Wako, Osaka, Japan), followed by a
horseradish peroxidase-conjugated goat anti-mouse IgG anti-
body (Saito et al., 2005). Reactive bands were visualized with
enhanced chemiluminescence (ECL) reagent (GE Healthcare
UK Ltd.).
FACScan FLOW CYTOMETRIC ANALYSIS OF CELL SURFACE RECEPTORS
Transfected HEK293T cells in 24-well plates were fixed with 1.5%
paraformaldehyde-PBS solution for 10min at room temperature,
then incubated with 0.25μg/ml anti-Flag M2 antibody in PBS
containing 20% FBS for 1 h. The cells were washed three times
with PBS and then incubated with Alexa Fluor 488-conjugated
goat anti-mouse IgG secondary antibody (Molecular Probes,
Eugene, OR, USA) for 1 h (Tetsuka et al., 2004; Saito et al., 2005).
The cells were washed, harvested with 5mM EDTA and analyzed
using a FACSCalibur flow cytometer (BD, Franklin Lakes, NJ).
Cells were gated by light scatter or exclusion of propidium iodide,
and 10,000 cells were acquired for each time point. The mean flu-
orescence of all cells minus the mean cell fluorescence with the
Alexa Fluor 488-conjugated secondary antibody only was used for
the calculations.
IMMUNOFLUORESCENCEMICROSCOPY
Transfected HEK293T cells were fixed in a 3.7%
paraformaldehyde-PBS solution for 10min. After two washes
with PBS, the cells were transferred, either with or without per-
meabilization using 0.05% Triton X-100 in PBS for 15min, into
a blocking solution (20% goat serum in PBS) for 30min, then
incubated with 0.5μg/ml anti-FlagM2 antibody for 1 h. The anti-
Flag M2 antibody was detected using Alexa Fluor 488-conjugated
goat anti-mouse IgG secondary antibody. Fluorescence imaging
was performed using a BZ-9000 microscope (Keyence, Tokyo,
Japan). For fluorescence imaging of MCH-induced receptor
internalization, cells were pre-incubated at 37◦C in serum-free
DMEM for 3 h. Cells were then incubated with 1μM rat MCH
for 10, 30, and 60min at 37◦C in a 5% CO2 incubator. Cells were
fixed, permeabilized and then incubated with 0.5μg/ml anti-Flag
M2 antibody in PBS containing 20% FBS for 1 h. The cells were
washed three times with PBS and then incubated with Alexa
Fluor 488-conjugated goat anti-mouse IgG secondary antibody
for 1 h. Fluorescence imaging was performed using a FLUOVIEW
FV1000 confocal microscope (Olympus, Tokyo, Japan).
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MEASUREMENT OF INTRACELLULAR Ca2+
Measurement of intracellular Ca2+ was performed as described
previously (Saito et al., 2003, 2005; Tetsuka et al., 2004).
Transiently transfected cells seeded in 96-well plates were loaded
with a non-wash calcium dye (Calcium Assay Kit 5, Molecular
Devices Japan, Tokyo, Japan) in Hank’s balanced salt solu-
tion containing HEPES (pH 7.5) for 1 h at 37◦C. For each
concentration of MCH, the level of [Ca2+]i was detected
using a FlexStation 3 Microplate Reader (Molecular Devices).
The data were expressed as fluorescence (arbitrary units) vs.
time. The EC50 values for MCH were obtained from sig-
moidal fits using a non-linear curve-fitting program (Prism v3.0;
GraphPad Software, San Diego, CA, USA). Rat/mouse/human
MCH and Compound 15 were purchased from Peptide Institute
(Osaka, Japan) and Bachem AG (Bubendorf, Switzerland),
respectively.
GTPγS-BINDING ASSAY
GTPγS-binding assay was performed as described previously
(Saito et al., 2005). Aliquots (10μg) of membrane proteins were
incubated in GTPγS binding buffer (20mM HEPES-NaOH pH
7.5, 100mM NaCl, 5mM MgCl2, 0.2% BSA and 3μM GDP)
containing 0.2 nM [35S]GTPγS (PerkinElmer, Santa Clara, CA,
USA) and various concentrations of MCH for 30min at 30◦C.
To determine the non-specific binding, unlabeled GTPγS was
added to the bindingmixtures to a final concentration of 100μM.
Bound [35S]GTPγS was separated from free [35S]GTPγS by rapid
filtration through GF/C filters and washed with ice-cold bind-
ing buffer. Filters were then immersed in scintillation cocktail
(Emulsion-Scintillator Plus; Packard Bioscience, Groningen, The
Netherlands) and trapped radioactivity counted using a liquid
scintillation counter.
MOLECULAR MODELING
To generate homology models of rat MCHR1 mutant F318K, we
used the X-ray structure of constitutively active rhodopsin bound
to the C-terminus peptide of the α-subunit of the G protein,
transducin (PDB code 2X72), as a structural template. Alignment
analysis in sequences of rat MCHR1 and rhodopsin was per-
formed using CLUSTALW2.0 installed in Genetyx v9.0 (Genetyx
Corporation, Tokyo, Japan). Initial models of ratMCHR1mutant
F318K with K341L transducin C-terminus peptide (340–350;
ILENLKDCGLF) was constructed using the Modelor module
installed in Discovery Studio (DS) v3.0 (Accelrys, Tokyo, Japan).
After replacement of L341 and E342 to Lys and Asn, the struc-
ture of rat MCHR1(F318K) bound to a C-terminus peptide
(343–353; IKNNLKDCGLF) of the Gαi subunit was optimized
using the molecular mechanics and molecular dynamics sim-
ulation with a CHARMm force field in the DS. Furthermore,
replacement of the Gαi peptide with a C-terminus peptide
to the Gαq subunit (349–359; LQLNLKEYNLV) and subse-
quent similar optimization in DS provided the model structure
of rat MCHR1(F318K) bound to the Gαq C-terminus pep-
tide. The X-ray structure of rhodopsin (PDB code 2X72) and
the two constructed models (rat MCHR1(F318K)-Gαi peptide
and rat MCHR1(F318K)-Gαq peptide) were superimposed for
comparison.
RESULTS
EFFECTS OF VARIOUS SINGLE-SITE ALA SUBSTITUTIONMUTATIONS
OF THE CONSERVEDNPxxY(x)5,6F motif ON RECEPTOR EXPRESSION
AND ACTIVITY
First, to analyze the function of the NPxxY(x)5,6F motif, a
series of Ala-substituted mutants were generated, as shown in
Figure 1A. We transiently transfected Flag-tagged MCHR1 or
mutant receptors into HEK293T cells, then examined receptor
expression levels by western blotting analysis using an anti-
Flag M2 antibody. Several immunoreactive bands were detected
in the whole lysate isolated from cells expressing Flag-MCHR1
(Figure 1B), some of which corresponded to the predicted molec-
ular masses of MCHR1 variants (approximately 35, 44, 45, and
60 kDa (Saito et al., 2003, 2005; Tetsuka et al., 2004), although
additional immunoreactive bands were observed at 45–60 kDa.
FIGURE 1 | Analysis of the effects of individual substitution mutations
in the NPxxY(x)5,6F motif of MCHR1 on receptor function in HEK293T
cells. (A) Schematic representation of the conserved NPxxY(x)5,6F motif
and the C-terminal tail of the rat MCHR1. The C-terminal tail of rat MCHR1
extends 42 residues from the plasma membrane (residue 312–353) and is
predicted to include an eighth cytoplasmic helix (helix 8) (Tetsuka et al.,
2004). Amino acid residues targeted for mutational analyses are underlined.
TM7; transmembrane 7. (B) Protein expression of Flag-MCHR1 and mutant
receptors. After lysis of transfected cells with SDS-sample buffer, 15μg
total protein was separated by 15% SDS-PAGE, transferred to a polyvinyl
difluoride membrane, and immunoblotted with an anti-Flag M2 antibody.
Four major immunoreactive bands of 35, 44, 45, and 60 kDa are present in
Flag-MCHR1 and individual mutant receptors. (C) Cells transfected with
Flag-MCHR1 or substitution mutant receptors were stimulated with the
indicated concentrations of MCH, and the subsequent changes in
cytoplasmic free Ca2+ levels were measured using a FlexStation. Results
shown are representative of at least three-independent experiments.
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Our previous study revealed that the 35-kDa band is the non-
glycosylated form of MCHR1 (Saito et al., 2003), while the three
higher molecular mass bands are different N-linked glycosylated
forms. The migration patterns of N307A, Y311A, and F318A
were very similar and no significant reductions in the intensity of
the higher molecular mass bands were observed relative to Flag-
MCHR1. However, the pattern in P308A was different, with the
expression of the higher molecular mass band at 60 kDa appar-
ently drastically reduced (Figure 1B, arrow). This phenomenon
is likely caused by a lack of appropriate glycosylation of the
mutant receptors, as previously shown in an-N-linked glycosy-
lation study and other MCHR1 studies (Saito et al., 2003; Aizaki
et al., 2009). The cell surface expression levels of Flag-MCHR1
and mutants containing Ala-substitutions in the NPxxY(x)5,6F
motif were monitored by FACScan flow cytometry using an
anti-Flag M2 antibody. Transient transfection of N307A and
Y311A gave expression levels of 23% and 30%, respectively, rel-
ative to that of Flag-MCHR1, while the F318A mutation was
expressed at approximately the same level as the non-mutated
control (Table 1). Conversely, P308A expression was reduced
by more than 90% compared to Flag-MCHR1, suggesting that
the mutant was mostly retained intracellularly (Figure 1B and
Table 1).
Next, we assessed the capacity of receptors containing alanine
mutations in their NPxxY(x)5,6F motif to induce intracellular
signals in response to MCH. MCH-induced calcium influx was
quantified in transiently transfected cells using a FlexStation 3
Microplate Reader. Mock-transfected HEK293T cells acted as a
negative control and did not respond to MCH stimulation (data
not shown). Considerable evidence suggests that most single-
substitution mutations of highly conserved amino acids (such
as the DRY or NPxxY(x)5,6F motifs) lead to impairment or
inactivation of receptor protein signaling. Indeed, substitution
of conserved Pro308 with Ala (P308A) resulted in a dramatic
attenuation of cell surface expression (Table 1). Therefore, this
receptor did not respond to MCH by calcium mobilization
(Figure 1C, Table 2), even when challenged with a high concen-
tration (10μM) of MCH.
Table 1 | Cell surface expression of Flag-MCHR1 and variants
transiently expressed in HEK293T cells.
Receptor Cell surface expression (FACS, %)
Flag-MCHR1 100
N307A 77.3 ± 0.3b
P308A 6.3 ± 1.0b
Y311A 69.3 ± 9.2a
F318A 91.0 ± 8.7
F318R 90.5 ± 9.5
F318K 96.2 ± 5.8
F318P 90.2 ± 9.1
The data represent the mean ± S.E.M of three or four-independent experiments
performed in triplicates.
aP < 0.05, significantly different from Flag-MCHR1 by Student’s t-test.
bP < 0.01, significantly different from Flag-MCHR1 by Student’s t-test.
Substitution of either Asn307 or Tyr311 with Ala also sig-
nificantly affected MCH-induced calcium mobilization. N307A
and Y311A mutant receptors exhibited a maximal response that
was 20–30% lower than wild-type receptors and had EC50 values
that were 21- and 8-fold higher, respectively, than Flag-MCHR1
(Table 2). However, the effects of alanine mutation of Phe318
in the highly conserved motif were distinct from other mutants
(Delos Santos et al., 2006; Duvernay et al., 2009; Málaga-Diéguez
et al., 2010; Kaye et al., 2011). The EC50 and maximal response
of MCH-induced calcium signaling in cells expressing the F318A
mutant were essentially identical to those of Flag-MCHR1. This
is consistent with our previous data (Tetsuka et al., 2004). These
results indicate that the conserved Phe in MCHR1 has a distinct
signaling role as compared with other conserved amino acids in
the NPxxY(x)5,6F motif.
EFFECTS OF INDIVIDUAL SUBSTITUTION OF HIGHLY CONSERVED PHE
ONMCHR1 FUNCTION
To further analyze the effect of the Phe318 substitution in the
NPxxY(x)5,6F motif, we performed site-directed mutagenesis of
Phe318 to proline, a change that is thought to disrupt helix forma-
tion and may cause drastic changes in receptor function. We also
mutated Phe to Arg and Lys, because these substitutions impart
a positive charge to the position. Analysis of receptor expres-
sion levels by western blotting analysis with the anti-Flag M2
antibody showed that the migration patterns of F318A, F318P,
F318R, and F318K were very similar and no drastic reduction in
the intensity of the higher molecular mass bands were observed
compared to Flag-MCHR1 (Figure 2A). We next determined the
expression characteristics of each mutant by quantifying cell sur-
face expression and observing subcellular distribution. The cell
surface expression levels of F318A, F318P, F318R, and F318K
caused no significant decrease as compared to the Flag-MCHR1
(Table 1). Antibody staining in non-permeabilized cells revealed
that F318A, F318P, F318R, and F318K were clearly localized in
the plasmamembrane, and their labeling intensities were approx-
imately equivalent with that of Flag-MCHR1 (Figure 3, upper).
In permeabilized cells, all four mutants were also predominantly
detected in the plasmamembrane, as was Flag-MCHR1 (Figure 3,
bottom). These results confirmed that both the level of cell surface
expression and the subcellular localization were unaffected by the
Phe318 substitution in the NPxxY(x)5,6F motif. This is in marked
Table 2 | Calcium mobilization stimulated by MCH via Flag-MCHR1
and variants [containing various single point mutations in the highly
conserved NPxxY(x)5,6F motif] expressed in HEK293T cells.
Receptor EC50 of MCH (nM) Maximum response (%)
Flag-MCHR1 1.5 ± 0.4 100
N307A 32.5 ± 9.0 83.5± 5.4
P308A – –
Y311A 12.2 ± 2.3 77.3± 10.0
F318A 1.2 ± 0.3 101.0 ± 8.2
P308A does not respond to MCH (–). The results represent the mean ± S.E.M.
of at least three-independent experiments performed in duplicate.
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FIGURE 2 | Analysis of the effects of substitution mutations of the
highly conserved Phe318 in the MCHR1 NPxxY(x)5,6F motif on receptor
function in HEK293T cells. (A) Protein expression of Flag-MCHR1 and
mutant receptors. After lysis of transfected cells with SDS-sample buffer,
15μg total protein were separated by 15% SDS-PAGE, transferred to a
polyvinyl difluoride membrane, and immunoblotted with an anti-Flag M2
antibody. Four major immunoreactive bands of 35, 44, 45, and 60 kDa are
present in Flag-MCHR1 and individual mutant receptors. (B) Dose-response
relationship of MCH-stimulated calcium influx in HEK293T cells expressing
Flag-MCHR1 or mutant receptors. Cells transfected with Flag-MCHR1 or
the substitution mutant receptors were stimulated with the indicated
concentrations of MCH, and the subsequent changes in cytoplasmic free
Ca2+ levels were measured using a FlexStation. Results shown are
representative of at least three-independent experiments.
contrast with similar mutants of other GPCRs including the
α2B-AR (Delos Santos et al., 2006; Duvernay et al., 2009; Málaga-
Diéguez et al., 2010), in which membrane translocation was
dramatically impaired by mutation of the conserved Phe residue
in the NPxxY(x)5,6F motif. Using fluorescence microscopy, we
also examined the features of receptor internalization following
exposure to MCH, because rat MCHR1 undergoes rapid MCH-
induced internalization during the 30min after stimulation (Saito
et al., 2004). Consistent with this previous study, treatment with
MCH for 30min caused a loss of membrane localization and the
appearance of MCHR1-containing vesicles. This distribution was
also observed following 60min of incubation. A similar time-
course ofMCH-induced receptor internalizationwas obtained for
the F318K mutant (Figure 4).
The effects of Phe318 mutations on MCHR1 responsiveness
to MCH in calcium mobilization are shown in Table 3 and
Figure 2B. In cells expressing single-substitution mutants, the
MCH EC50 was 7.8 nM and 0.8 nM for F318P and F318R, respec-
tively, with identical maximal responses. Importantly, MCH had
FIGURE 3 | Confocal immunolocalization of Flag-MCHR1 and the
mutant receptors using an anti-Flag M2 antibody in HEK293T cells.
Cell surface expression was compared using transfected non-permeabilized
cells (-TX100, without Triton X-100; upper row) and permeabilized cells
(+TX100, with Triton X-100; lower row). Vector-transfected cells incubated
with the anti-Flag M2 antibody showed no significant staining (data not
shown). Bar, 10μm.
FIGURE 4 | MCH-mediated receptor internalization in HEK293T cells.
Cells expressing MCHR1 or the F318K mutant were stimulated with 1μM
MCH for the time shown, fixed and imaged by confocal fluorescence
microscopy. Prior to MCH addition, cells were incubated with serum-free
DMEM for 3 h. Bar, 10μm.
increased potency in releasing calcium via the F318K mutant
receptor (EC50 = 0.4 ± 0.1 nM, compared with 2.5 ± 0.8 nM for
Flag-MCHR1, Table 3), although the maximal response was
unchanged. We also mutated the uncharged hydrophobic Phe to
other uncharged polar amino acid residues (Gly, Ser, and Cys), a
different hydrophobic residue (Trp) and a different basic residue
(His) and measured the responsiveness of the resultant mutant
receptors in the calciummobilization assay (Table 3). Among the
mutants, F318K and F318R exhibited significantly enhanced cel-
lular signaling, but F318K caused a higher responsiveness than
F318R. In addition to using MCH itself, we also tested the activity
of the mammalianMCH analog, Compound 15, which efficiently
binds with high affinity to MCHR1 (Bednarek et al., 2002). The
potency of Compound 15 was also enhanced in cells express-
ing F318K compared to Flag-MCHR1 (0.15 ± 0.10 nM vs. 1.3 ±
0.4 nM, respectively; mean ± S.E.M. from three-independent
experiments). This enhanced response to MCHwas also observed
when F318Kwas transiently transfected into CHO cells and COS7
cells (data not shown).
To elucidate further the effect of Lys mutation, mutagenesis
of single or multiple residues around Phe318 was performed,
as shown in Figure 5. The E316K, T317K, and R319K/R321K
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Table 3 | Calcium mobilization by MCH via Flag-MCHR1 and variants
[containing single point mutations at F318 in the NPxxY(x)5,6F motif]
expressed in HEK293T cells.
Receptor EC50 of MCH (nM) Maximum Response (%)
Flag-MCHR1 2.5 ± 0.8 100
F318A 1.2 ± 0.2 92.4 ± 7.2
F318P 7.8 ± 3.2a 93.7 ± 11.4
F318R 0.8 ± 0.3b 99.4 ± 3.0
F318K 0.4 ± 0.1b 102.0 ± 8.0
F318G 2.3 ± 0.9 99.6 ± 9.8
F318S 2.4 ± 0.7 104.7 ± 18.7
F318C 9.7 ± 1.2b 101.3 ± 17.7
F318W 3.1 ± 1.3 102.6 ± 9.2
F318H 3.6 ± 0.7 92.3 ± 16.7
E316K 2.2 ± 0.5 99.7 ± 10.9
T317K 3.8 ± 0.9 82.6 ± 6.4a
R319K/R321K 2.6 ± 0.5 84.8 ± 9.5a
Results represent the mean ± S.E.M. of at least three-independentexperiments
performed in duplicate.
aP < 0.05, significantly different from Flag-MCHR1 by Student’s t-test.
bP < 0.01, significantly different from Flag-MCHR1 by Student’s t-test.
mutations resulted in no higher potency or efficacy of MCH
in the calcium mobilization assay. Instead, the T317K and
R319K/R321K mutants had a significantly depressed maximal
response relative to Flag-MCHR1 (Table 3, Figure 5). Taken
together, the activity of MCHR1 in calcium mobilization is
enhanced by the introduction of a positively charged Lys residue
at the 318 position, but not at the adjacent amino acid residues,
indicating that the 318 position seems to be critical for receptor
conformation and/or receptor interaction with the Gα proteins
that mediate calcium signaling. We then investigated the effects
of a similar mutation in human MCHR2, the human ortholog of
rat MCHR1. The corresponding Phe in MCHR2 was mutated to
Lys (F313K) and tested forMCH responsiveness in calciummobi-
lization, since MCHR2 is known to couple exclusively to Gαq (An
et al., 2001). As shown in Table 4, however, F313K was no more
responsive than the non-mutated receptor, and rather showed
a 22% reduced maximal response. These results imply that the
effect of the Phe-to-Lys substitution on receptor signaling seems
to be a specific and intrinsic feature of MCHR1.
SELECTIVITY OF F318K FOR G PROTEINS IN MCHR1
MCHR1-stimulated calcium signaling is mediated through both
Gαq- and Gαi/o-dependent pathways (Hawes et al., 2000;
Tetsuka et al., 2004). To confirm which G protein was pri-
marily responsible for the enhancement of calcium signal-
ing by the F318K receptor, we used pertussis-toxin (PTX)
to uncouple Gαi/o from MCHR1. In cells expressing Flag-
MCHR1, PTX pretreatment increased the EC50 value to 3.6 ±
0.6 nM (compared to 1.1 ± 0.3 nM in untreated cells), which
equates to a +PTX (PTX-insensitive, Gαq-dependent response)/-
PTX (combined Gαi/o and Gαq-dependent response) ratio
of 3.30 (i.e., 3.6/1.1 nM). Following PTX pretreatment, the
EC50 of MCH in cells expressing F318K was 0.48 ± 0.08 nM
FIGURE 5 | Effects on receptor activity of substitution mutations of the
residues adjacent to Phe318 in HEK293T cells. (A) Sequences of
Flag-MCHR1 and three mutants for which native residues were replaced
with Lys (E316K, T317K and R319K/R321K). (B) Dose-response relationship
of MCH-stimulated calcium influx in HEK293T cells expressing
Flag-MCHR1 or substitution mutant receptors. Cells transfected with
Flag-MCHR1 or substitution mutant receptors were stimulated with the
indicated concentrations of MCH, and the subsequent changes in
cytoplasmic free Ca2+ levels were measured using a FlexStation. Results
shown are representative of at least three-independent experiments.
Table 4 | Signaling of human MCHR2 and its single-substitution
(F313K) mutant after transfection into HEK293T cells.
Receptor EC50 of MCH (nM) Maximum response (%)
MCHR2 5.2 ± 2.5 100
F313K/MCHR2 5.4 ± 2.4 78.7 ± 7.7
Since the F313 residue corresponds to F318 in rat MCHR1, the F313K mutant
of human MCH2R was analyzed for its effect on receptor signaling to cal-
cium mobilization. The data represent the mean ± S.E.M of three-independent
experiments performed in duplicate.
(compared to 0.13 ± 0.03 nM in untreated cells), giving a
+PTX/−PTX ratio of 3.70. The maximal calcium response to
MCH at either receptor was not affected by the addition of PTX.
Because PTX reduced the potency of MCH but did not abol-
ish its effect, it is clear that F318K and Flag-MCHR1 both drive
calcium influx by a combination of Gαq- and Gαi/o-dependent
pathways. Because MCH still stimulated calcium influx at a
lower agonist concentration in F318K after treatment of PTX
(EC50 = 3.6 nM at Flag-MCHR1 vs. 0.48 nM at F318K), it is
clear that PTX-insensitive Gαq protein is involved in mediat-
ing calcium responses in both receptors. However, the ratio
of MCH potency in the presence and absence of PTX was
remarkably similar in both mutated and non-mutated recep-
tors, suggesting that the selectivity of the mutant receptor is
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likely to be the same as in the wild-type receptor (i.e., that
the mutation has not introduced a strong preference for Gαq).
However, calcium signals by Gαq tend to dwarf those induced
by Gαi/o in HEK293T cells (Tetsuka et al., 2004), so it is diffi-
cult to judge what effect the mutation has on the ability of the
receptor to couple to Gαi/o. Thus, it was necessary to analyze
other signal transduction events related toMCHR1-Gαi/o protein
interactions.
It has been shown previously that MCH stimulation of cells
expressing MCHR1 can activate a Gαi/o-mediated pathway to
cause a decrease in adenylyl cyclase activity, thus reducing cAMP
production (Chambers et al., 1999; Saito et al., 1999; Hawes et al.,
2000). We therefore tried to measure the interaction between
MCHR1 and Gαi/o in cells where cAMP accumulation had been
induced by forskolin. Although stable clones for F318K were
established, their signaling profiles were very different to tran-
siently transfected cells. For instance, F318K clones were unable to
inhibit forskolin-stimulated cAMP accumulation, even at MCH
concentrations up to 100 nM MCH (data not shown). These
results suggest that the F318K stable clones have lost the abil-
ity to couple to Gαi/o protein. Because the amount of total
protein and the glycosylation pattern of these proteins in cells
were equivalent to that of Flag-MCHR1 (as determined by west-
ern blotting), the uncoupling from Gαi/o in stably-transfected
cells may be due to some aberration in structure and/or func-
tionality when cultured long-term in the presence of antibiotic
selection.
Given the difficulties in measuring Gαi/o protein activation
using cAMP assays in stable clones, we employed an alternative
technique. It is well-established that the key step in GPCR activa-
tion is the induction of guanine nucleotide exchange (GDP-GTP)
on the G protein α-subunit. The nucleotide exchange process
can be monitored by measuring the binding of non-hydrolyzable
GTPγS analog, [35S]GTPγS. Because the Gαi family of G pro-
teins has a substantially higher basal rate of guanine nucleotide
exchange than other G proteins, this assay is ostensibly a measure
of GPCR-mediated activation of Gαi/o proteins (Milligan, 2003).
Indeed, the GTPγS binding assay has been widely used to mea-
sure the activation of Gαi proteins by various GPCRs. Therefore,
we examined both basal and MCH-stimulated [35S]GTPγS bind-
ing using the membrane fraction of HEK293T cells transiently
expressing Flag-MCHR1 and the F318K mutant (Figure 6). In
cells expressing Flag-MCHR1, MCH dose-dependently stimu-
lated binding of GTPγS with an EC50 value of 0.23 ± 0.07
nM, while the value for F318K was 0.47 ± 0.25 nM (mean ±
S.E.M. from three-independent experiments). The values for
F318K were slightly higher, but a significant difference was not
observed. The maximal amount of binding for Flag-MCHR1
with 1μM MCH was 208.3 ± 25.2% of basal, while that for
F318K was 190.6 ± 20.3% of basal. Overall, there was no differ-
ence in the amount of GTPγS binding between cells expressing
Flag-MCHR1 and the F318K mutant, in contrast to the clear
influence of the F318K mutation on Gαq-mediated signaling.
There was no significant difference in basal GTPγS binding
(100% for Flag-MCHR1 vs. 97.6 ± 0.4% for F318K), suggest-
ing that the F318K mutation does not affect constitutive receptor
activation.
FIGURE 6 | MCH-induced [35S]GTPγS binding to Flag-MCHR1 and
F318K. HEK293T cells were transfected with Flag-MCHR1 or F318K. After
48h, the cells were harvested and the membrane fractions recovered.
Membrane proteins (10μg) were subsequently incubated with 0.2 nM
[35S]GTPγS and 0.001–1000nM MCH in GTPγS binding buffer for 30min at
30◦C. The amounts of radioactivity bound to the membrane preparations
are shown for Flag-MCHR1 (filled circles) and F318K (open circles). Results
shown are representative of three-independent experiments.
INTERPRETATIONOF THE FUNCTIONAL IMPORTANCE OF F318K
IN MCHR1
To understand better how the signaling dynamics of F318K are
related to its interaction with (and activation of) Gαq, we con-
structed a molecular model of F318K activation of G protein
based on that for the active structure of rhodopsin in com-
plex with a transducin peptide as a reference (Kleinau et al.,
2010). Because MCHR1 belongs to the same GPCR subfamily as
rhodopsin, the existing rhodopsin sequence alignment allowed
us to construct a preliminary model of MCHR1 conformation.
We refined this model to account for the specific properties of
MCHR1 using software for protein model building and a molec-
ular dynamics software package. Our model highlighted several
putative amino acid contacts between the receptor and Gαq pro-
tein, notably at intracellular loop 1 (i1) and helix 8 (Figure 7,
left). Lys318 is predicted to interact efficiently with Asp79 (located
in i1) via a distinct hydrogen-bonding pattern, and these two
residues create an accessible intracellular interface for the Asn357
residue in the Gαq protein. However, Asp79 in i1 also exists
in human MCHR2, in which F313K had no effect on MCH
potency in calcium signaling, as shown in Table 4. We therefore
searched for alternative candidate residues that may be involved
in the interaction with Asn357 by comparing sequences between
rat MCHR1 and other GPCRs, including human MCHR2. The
sequences we used are for GPCRs in which mutation at the
position corresponding to Phe318 of MCHR1 did not produce
increased signaling potency (Fritze et al., 2003; Delos Santos et al.,
2006; Anavi-Goffer et al., 2007; Duvernay et al., 2009; Málaga-
Diéguez et al., 2010; Kaye et al., 2011). By making multiple
alignments of these sequences, we found several amino acid inser-
tions in i1 that occurred only in rat MCHR1, and were absent
in other GPCRs (Table 5). Notably, a sequence in i1 includes
Trp73, which possesses a bulky, aromatic side chain. Hydrophobic
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FIGURE 7 | Structural analysis of critical amino acids in a proposed
model of rat MCHR1 mutant F318K with Gαq or Gαi proteins.
Homology model of rat MCHR1 mutant F318K was constructed using the
crystal structure of rhodopsin E113Q mutant in complex with the C-terminal
tail of transducin (PDB ID 2X72). Amino acid residues involved in coupling
to Gαq or Gαi proteins in intracellular loop 1 (i1) and K318 in helix 8 are
shown. (A) The model structure of MCHR1(F318K)-Gαq C-terminal tail. The
area demarcated by the square is magnified below in panel (C). (B) The
model structure of MCHR1(F318K)-Gαi C-terminal tail. The area demarcated
by the square is magnified below in panel (D). (C) Positions of Lys318,
Tyr311, Trp73, and Asp79 residues and their position relative to Asn357 of
Gαq. This model depicts the hydrogen bond network between Lys318 and
Asp79 in the receptor and Asn357 in Gαq C-terminal tail. Note that
interactions between Trp73 in i1 loop and Asn357 in the G protein
C-terminal tail. Green, red, and blue areas indicate carbon, oxygen and
nitrogen atoms, respectively, within the key residues of the receptor.
Carbon atoms in the Gαq protein are colored cyan. (D) Magnified view of
Lys318, Tyr311, Trp73, and Asp79 residues in the receptor and their position
relative to Gly351 of Gαi. Intramolecular hydrogen interactions predicted
between Lys318 and Asp79 in the receptor are shown. Carbon atoms in the
Gαi protein are colored yellow.
interaction of Trp73 with Asn357 in the Gαq C-terminal tail
is predicted to stabilize the intracellular interaction between
MCHR1 and Gαq. Conversely, the Gly351 residue in Gαi has
no side chain to interact with Lys318 (Figure 7, right), which
may explain the lack of enhancing effect of the F318K muta-
tion on Gαi-mediated signaling. Collectively, a predicted model
of F318K combined with sequence alignments suggests that the
key residues of the MCHR1-Gαq interface are Trp73 and Asp79
in the receptor and Asn357 in the Gαq protein. We speculate
that the F318K mutation somehow enhances this interface, either
by promoting heightened interaction or by facilitating G protein
activation, possibly by changing the binding affinity (see section
“Discussion”).
DISCUSSION
Recent studies have underscored that, the Phe residue is a key
position in the conserved NPxxY(x)5,6F motif, which connects
TM7 and helix 8 (Palczewski et al., 2000; Fritze et al., 2003).
Indeed, of 180 class A GPCRs, this Phe residue is the most
highly conserved in 135 of these receptors (Okuno et al., 2005).
Mutation of the conserved Phe to Ala in rhodopsin and the
M1 muscarinic acetylcholine receptor considerably reduced the
potency in Gαt- and Gαq-mediated signaling, respectively (Fritze
et al., 2003; Kaye et al., 2011). Furthermore, Phe-to-Ala substi-
tution in this motif dramatically reduced cell surface expression
of α2B-AR, resulting in extensive ER arrest (Duvernay et al.,
2009). These data suggest that the highly hydrophobic Phe residue
in the conserved NPxxY(x)5,6F motif of many GPCRs is neces-
sary for the maintenance of proper receptor conformation, and
is often involved in receptor export from the ER. In the present
study, we showed that Phe-to-Ala substitution (F318A) in rat
MCHR1 did not significantly affect either the level of cell sur-
face expression orMCH-induced calciummobilization. However,
by analyzing a series of substitution mutants, Phe-to-Lys substi-
tution led to the most increased MCH potency in stimulating
calcium mobilization, a pathway largely mediated via Gαq. In
contrast, F318K had no significant effect in the GTPγS-binding
assay that measures receptor interaction with Gαi protein. These
findings are surprising considering that they contradict findings
in Phe substitutions of other GPCRs. Therefore, our study pro-
vides new insight into the role of the NPxxY(x)5,6F motif Phe
residue in term of G protein activation. Although the consen-
sus is that this residue is a key determinant of receptor struc-
ture and function, its effect may be dependent on the specific
sequence of the receptor and the presence or absence of other
residues that make up the receptor-G protein binding/activation
interface.
We showed that MCH was the most potent in stimulating cal-
ciummobilization in cells expressing F318K among our mutants.
To date, many mutations or truncations in MCHR1 have been
designed to study the roles of certain residues and sequences in
the diverse functionality of the receptor (Macdonald et al., 2000;
Saito et al., 2003, 2004, 2005; Tetsuka et al., 2004; Fan et al., 2005).
Some caused a slight or moderate decrease in calcium mobiliza-
tion (Saito et al., 2003, 2004) and the others resulted in more
severe impairment or loss of function (Macdonald et al., 2000;
Tetsuka et al., 2004; Fan et al., 2005; Saito et al., 2005; Aizaki et al.,
2009). F318K is, therefore, the first mutation characterized by an
active variant with more efficient signaling properties. We con-
clude that substitution of Phe318 with the moderately positively
charged Lys is most responsible, at least in part, for producing
increased MCH potency in stimulating calcium mobilization via
MCHR1. Replacement with another positively charged amino
acid, His, at the 318 position had no effect for signaling enhance-
ment. Furthermore, the highly positively charged Arg could not
induce equivalent effects to F318K (Figure 2, Table 3). These
findings suggest that unique and strict physicochemical charac-
teristics, including the extent of positive charge, polarity and the
size of the side chain, may be required for this phenomenon to
occur.
GPCRs that bind promiscuously to several Gα protein sub-
types are useful tools for clarifying the determinants of G protein
selectivity. To date, most studies of rhodopsin family GPCRs have
emphasized the role of membrane-proximal regions in the i2 and
i3 loops and/or the cytoplasmic loop of the receptor (Anavi-
Goffer et al., 2007; Kunieda et al., 2007; Kleinau et al., 2010).
Our present data suggest that MCHR1 couples to both Gαi and
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Table 5 | Amino acid sequence alignment from the transmembrane 1 (TM1) to TM3 of rat MCHR1 and other GPCRs.










Stars beneath sequence indicate sequence identity across the alignment, and single dot indicates conserved substitutions.
hMCHR2, human MCHR2; rmAChR1, rat muscarinic acetylcholine receptor M1; rA1AR, rat adenosine 1A receptor; ra(2B)-AR, rat α2B adrenergic receptor; hb1AR,
human β1 adrenergic receptor; bovineRho, bovine rhodopsin; hCB1, human cannobinoid receptor 1.
Gαq proteins via overlapping intracellular regions but that Lys
mutation of the 318 position in the NPxxY(x)5,6F motif appears
to affect only the coupling of the receptor to Gαq. Phe318 is
located in the juxtamembrane helix 8 in the C-terminal tail. The
role of helix 8 is believed to be in regulating G protein acti-
vation by GPCRs, yet few studies have established the pivotal
role of helix 8 in G protein selectivity. The position in cannabi-
noid receptor 1 that corresponds to the MCHR1 Phe318 residue
is not a Phe but is a hydrophobic residue (Leu404), and the
L404I mutation led to impaired activation of Gαi3 but not GαoA
among the Gαi/o protein subgroup (Anavi-Goffer et al., 2007).
Furthermore, the positively charged Arg687 in helix 8 of the
thyrotropin receptor is important for selective interaction with
Gαq (Kleinau et al., 2010). In helix 8 of MCHR1, three basic
amino acid residues (Arg319, Lys320, and Arg321) are juxta-
posed with Phe318. This basic region in helix 8 seems not to
be involved in Gα protein coupling specificity, since alteration
of the positive charge of these residues (R319Q/K320Q/R321Q)
caused an equally strong inhibition of both Gαq and Gαi (Tetsuka
et al., 2004). Taken together, we might conclude that each amino
acid residue in helix 8 of MCHR1 may have different roles in
determining receptor activity and G protein selectivity. Our clari-
fication here of the significance of the Phe position will hopefully
allow additional understanding of dual G protein coupling in
other GPCRs.
Upon stimulation, GPCRs undergo a conformational change
that results in G protein activation. Light-induced conforma-
tional changes in rhodopsin were elucidated by a series of bio-
physical studies. Evidence indicates that an important hydropho-
bic pairing between Tyr306 and Phe313 in the NPxxY(x)5,6F
motif stabilizes the ground state of rhodopsin (Palczewski et al.,
2000; Nygaard et al., 2009). Comparative molecular dynamics
simulations of MCHR1 have also suggested that the release of
intramolecular interactions between the Tyr and Phe residues in
the motif is an important step in transitioning from an inactive
to an active form (Vitale et al., 2004). We initially hypothe-
sized that the Tyr311-Phe318-based switch in MCHR1, which
is the homolog of a crucial relay point in rhodopsin, would
be modified by substituting Phe with Lys, with disruption of
an aromatic stacking interaction in the resultant ternary com-
plex somehow affecting the efficacy of signaling. However, the
activated F318K structure bound with Gαq protein (Figure 7)
has suggested that an additional and distinct interface may exist
between Phe318 and Asp79 in the i1 loop. Further analysis with
multiple alignment data for other GPCRs showed that close prox-
imity of Phe318, Asp79, and Asn357 is insufficient to induce such
signaling changes and that Trp73 in the i1 loop may be impor-
tant in stabilizing/maintaining the efficient binding/activation
of the Gαq protein by the activated receptor. A series of com-
binational mutations involving F318K and several amino acid
residues in the i1 loop (Trp, Cys, and Ser, as described in Table 5)
may clarify the importance and role of each residue. A pre-
cise three-dimensional crystal structure of the MCHR1-G protein
complex would also facilitate our understanding, but our present
model helps to understand how a single amino acid substitu-
tion, F318K, can alter the intra-/inter-molecular interactions of
the receptor-G protein complex to modulate G protein signaling
via this receptor. At this time, we cannot exclude the possi-
bility that F318K has an increased binding affinity, although
the EC50 value of MCH in the GTPγS-binding assay showed
no change between Flag-MCHR1 and F318K. The concept of
modes in agonism of GPCRs has recently been expanding (Smith
et al., 2011), implying that receptors can convey different sig-
nals through different pathways with varying degrees of potency
or efficacy depending on the ligand used. Therefore, it may
be possible that the functional selectivity observed in F318K
results from enhancement of the binding affinity that favors
Gαq-binding but not Gαi-binding. Overall, based on our data,
we favor an interpretation that F318 is involved in receptor
dynamics.
In conclusion, by analyzing a series of mutants, we report for
the first time that F318K, a point mutation in the NPxxY(x)5,6F
motif of MCHR1, most efficiently enhances the potency of MCH
in stimulating calcium mobilization via MCHR1 without show-
ing any increase in cell surface expression. We speculate that
Phe318 might be involved in the interface between the recep-
tor and G protein, and may regulate which G proteins the
receptor can bind and activate. Because there are a limited
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number of GPCR mutant that significantly enhanced the signal-
ing (Reinscheid et al., 2005; Kato et al., 2008), F318K may provide
useful clues in understanding the process of intrinsic receptor
dynamics. However, further research is required to demonstrate
whether the role of Phe318 described here is of physiological and
functional significance.
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